Ovid Technologies GmbH Sample Clauses

Ovid Technologies GmbH. Licensed Material: Evidence-Based Medicine Reviews  Number of titles: N/A (mixed contents database)  Dates covered, if applicable: current  Description: A definitive resource in the evidence based medicine (EBM) movement that combines 7 of the most trusted EBM resources into a single, fully- searchable database comprehensively integrated with MEDLINE. Consists of Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effectiveness (DARE), Health Technology Assessments (HTA), NHS Economic Evaluation Database (NHSEED), ACP Journal Club, Cochrane Central Register of Controlled Trials and Cochrane Methodology Register (CMR). See xxxx://xxx.xxxx.xxx/site/catalog/databases/904.jsp for details. Agreement Term: Effective date – 31 December 2020 + optional 1 January 2021 – 31 December 2022 (minor differences marked in Appendix B) Access Conditions: Unlimited simultaneous user systemwide access (no perpetual rights!) Authentication: IP authentication (See Appendix C for IP addresses) Licensed Material: GEOREF  Number of titles: N/A (bibliographic database)  Dates covered, if applicable: covers the geology of North American from 1669 for North America and 1933 for the rest of the world  Description: GeoRef, published by the American Geosciences Institute, contains more than 3.7 million abstract records from geoscience journals, books, maps, conference papers and more. Established in 1966, the database includes also all publications of the US Geological Survey and adds 100,000 records every year. See xxxx://xxx.xxxx.xxx/site/catalog/databases/96.jsp for details. Agreement Term: Effective date – 31 December 2020 + optional 1 January 2021 – 31 December 2022 (minor differences marked in Appendix B) Access Conditions: Unlimited simultaneous user systemwide access (no perpetual rights!) Authentication: IP authentication (See Appendix C for IP addresses) Licensed Material: Medline on Ovid  Number of titles: N/A (bibliographic database)  Dates covered, if applicable: since 1946  Description: Updated daily, MEDLINE on the Ovid platform offers novice and expert searchers seamless and up-to-the-minute access to over 23 million of the latest bibliographic citations and author abstracts from more than 5,600 biomedicine and life sciences journals in nearly 40 languages (60 languages for older journals). English abstracts are included in more than 80% of the records. Access to Ovid MEDLINE In-Process & Other Non-Indexed Citations and provides Evidence...
AutoNDA by SimpleDocs
Ovid Technologies GmbH. Licensed Material: Evidence-Based Medicine Reviews Participating Institutions 2018 2019 2020 2021 2022 Remarks University Hospital Hradec Králové 1) National Medical Library 2) Xxxxxxx University 3) Palacký University Olomouc 1) Total (excl. VAT) Grand total (excl. VAT) Remarks:1) License level: 1 concurrent user per institution2) License level: 2 concurrent users per institution3) License level: 5 concurrent users per institution Licensed Material: GEOREF Participating Institutions 2018 2019 2020 2021 2022 Remarks Czech geological survey 1) Institute of Geology of the CAS 1) Xxxxxxx University Total (excl. VAT) Grand total (excl. VAT) Site licence Remarks:

Related to Ovid Technologies GmbH

  • EMERGING TECHNOLOGIES The State reserves the right to modify the terms of this Contract or any future Periodic Recruitments, to allow for emerging technologies. OGS reserves the right to include such technology(ies) hereunder or to issue a formal modification or amendment to this Contract.

  • New Technology When new or updated technology is introduced into a workplace, it will be the responsibility of the employer to provide appropriate and, if necessary, ongoing training to the employees directly affected. Such training will include any health and safety implications or information that will enable employees to operate the equipment without discomfort and will help maintain their general well-being.

  • Technology License 4.1 Unless any event described in Article 2.2 or 2.3 of this Agreement occurs, all of the technology required to be licensed for any of Party B’s business shall be provided by Party A on an exclusive basis. Party A will try its best to license Party B to use the technology owned by Party A, or re-license Party B to use the technology as approved by the owner.

  • Technology Discoveries, innovations, Know-How and inventions, whether patentable or not, including computer software, recognized under U.S. law as intellectual creations to which rights of ownership accrue, including, but not limited to, patents, trade secrets, maskworks and copyrights developed under this Agreement.

  • Technology Access A. Contractor expressly acknowledges that state funds may not be expended in connection with the purchase of an automated information system unless that system meets certain statutory requirements relating to accessibility by persons with visual impairments. Accordingly, Contractor represents and warrants to System Agency that the technology provided to System Agency for purchase (if applicable under this Contract or any related Solicitation) is capable, either by virtue of features included within the technology or because it is readily adaptable by use with other technology, of:

  • Third Party Technology Customer is hereby notified that third parties have licensed certain technology to Company, which is contained in the Software. Notwithstanding anything herein to the contrary, Customer hereby consents to the disclosure of Customer’s identity, and such other terms of this Agreement as necessary, to such third party licensors for the purpose of enabling Company to comply with the terms and conditions of such third party licenses. Any such Customer information will be provided pursuant to an obligation of confidentiality and nondisclosure at least as stringent as that imposed by this Agreement.

  • Background Technology List here prior contracts to assign Inventions that are now in existence between any other person or entity and you. [ ] List here previous Inventions which you desire to have specifically excluded from the operation of this Agreement. Continue on reverse side if necessary.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Sublicense to Use the Scudder Trademarks As exclusive licensee of the rights to use anx xxxxxcense the use of the "Scudder," "Scudder Investments" and "Scudder, Stevens & Clark, Inx." xxxdemaxxx (xxgether, the "Scuddex Xxxxx"), xxx xerexx xxant the Trust a nonexclusive right xxx xxxlicense to use (i) the "Scudder" name and mark as part of the Trust's name (the "Fund Namx"), xxd (ii) the Scudder Marks in connection with the Trust's investment products xxx xxxvices, in each case only for so long as this Agreement, any other investment management agreement between you or any organization which shall have succeeded to your business as investment manager ("your Successor") and the Trust, or any extension, renewal or amendment hereof or thereof remains in effect, and only for so long as you are a licensee of the Scudder Marks, provided however, that you agree to use your best xxxxxxx to maintain your license to use and sublicense the Scudder Marks. The Trust agrees that it shall have no right to suxxxxxxxe or assign rights to use the Scudder Marks, shall acquire no interest in the Scudder Marks othxx xxxx the rights granted herein, that all of txx Xxxxt's uses of the Scudder Marks shall inure to the benefit of Scudder Trust Company xx xxxer and licensor of the Scudder Marks (xxx "Xrademark Owner"), and that the Trust shall nxx xxxxlenge the validity of the Scudder Marks or the Trademark Owner's ownership thereof. The Truxx xxxxher agrees that all services and products it offers in connection with the Scudder Marks shall meet commercially reasonable standards of duaxxxx, xs may be determined by you or the Trademark Owner from time to time, provided that you acknowledge that the services and products the Trust rendered during the one-year period preceding the date of this Agreement are acceptable. At your reasonable request, the Trust shall cooperate with you and the Trademark Owner and shall execute and deliver any and all documents necessary to maintain and protect (including but not limited to in connection with any trademark infringement action) the Scudder Marks and/or enter the Trust as a registered user thereof. Xx xxch time as this Agreement or any other investment management agreement shall no longer be in effect between you (or your Successor) and the Trust, or you no longer are a licensee of the Scudder Marks, the Trust shall (to the extent that, and as soon ax, xx xawfully can) cease to use the Fund Name or any other name indicating that it is advised by, managed by or otherwise connected with you (or your Successor) or the Trademark Owner. In no event shall the Trust use the Scudder Marks or any other name or mark confusingly similar therexx (xxxluding, but not limited to, any name or mark that includes the name "Scudder") if this Agreement or any other investment advisory agrexxxxx xetween you (or your Successor) and the Fund is terminated.

  • Diagnostic Services Procedures ordered by a recognized Provider because of specific symptoms to diagnose a specific condition or disease. Some examples include, but are not limited to:

Time is Money Join Law Insider Premium to draft better contracts faster.